Clinical Trials Browser

Phase 4 × Lymphoma, Non-Hodgkin × Clear all

NCT06876649 2026-03-02

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Phase 4 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06876662 2026-03-02

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Phase 4 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT03229200 2025-10-30

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

Phase 4 Active not recruiting

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, B-Cell

NCT01909934 2025-09-19

Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

Phase 4 Completed

50 enrolled 22 charts

Hematologic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT07016165 2025-08-22

Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies

Phase 4 Recruiting

Classical hematologyLymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT04460235 2025-07-01

HEMATOVAC

Phase 4 Recruiting

Lymphoma, Non-Hodgkin

NCT06665737 2025-01-28

G-CSF in NHL

Phase 4 Not yet recruiting

Classical hematologyLymphoid

Lymphoma, Non-Hodgkin, Febrile Neutropenia

NCT00168727 2023-08-23

Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma

Phase 4 Completed

Lymphoma, Non-Hodgkin

NCT05191225 2022-03-31

Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study

Phase 4 Unknown

Lymphoma, Non-Hodgkin

NCT04134247 2019-10-22

Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL

Phase 4 Unknown

Lymphoma, Non-Hodgkin

NCT00003398 2019-10-17

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Phase 4 Completed

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Anemia, Blast Crisis, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Leukemia, Leukemia, Megakaryoblastic, Acute, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating

NCT04083079 2019-09-10

Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma

Phase 4 Unknown

Lymphoma, Non-Hodgkin

NCT01180049 2019-05-20

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

Phase 4 Completed

101 enrolled 15 charts

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT02717949 2019-01-08

Optimal

Phase 4 Terminated

Hepatitis C, Liver Diseases, Lymphoma, Non-Hodgkin

NCT00430352 2017-08-14

MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.

Phase 4 Completed

545 enrolled 12 charts

Lymphoma, Non-Hodgkin

NCT02585947 2016-12-21

To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma

Phase 4 Unknown

Burkitt Lymphoma, Lymphoma, Non-Hodgkin

NCT02996617 2016-12-19

PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia

Phase 4 Unknown

Lymphoma, Non-Hodgkin, Neutropenia, Lymphoma, B-Cell, Lymphoma, T-Cell

NCT02782845 2016-11-21

An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)

Phase 4 Completed

Lymphoma, Non-Hodgkin

NCT01698866 2016-06-16

EVACC-B

Phase 4 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT00352703 2014-11-03

PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation

Phase 4 Completed

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Stomatitis

NCT00808171 2014-07-29

Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture

Phase 4 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin

NCT01164475 2014-02-25

Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms

Phase 4 Completed

61 enrolled 19 charts

Lymphoma, Non-Hodgkin

NCT00969462 2013-07-01

Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma

Phase 4 Completed

Lymphoma, Non-Hodgkin

NCT00926757 2013-05-29

HBVNHL

Phase 4 Completed

Hepatitis B, Lymphoma, Lymphoma, Non-Hodgkin

NCT00114348 2013-02-04

ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia

Phase 4 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00162955 2012-05-08

Prevention of CHOP-induced Chronic Cardiotoxicity

Phase 4 Completed

Lymphoma, Non-Hodgkin, Cardiomyopathies

NCT00277160 2010-10-08

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Phase 4 Completed

BreastGynecologicLymphoidThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neutropenia, Ovarian Neoplasms

NCT01124526 2010-05-17

Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma

Phase 4 Completed

Lymphoma, Non-Hodgkin

NCT00090038 2009-10-20

Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma

Phase 4 Completed

Lymphoma, Non-Hodgkin

NCT00797810 2009-09-15

Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults

Phase 4 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma